OAT Agrio (4979) · RiskRestated
Commercialization and Regional Sales Risk in Joint Research in India
First written in FY2016. 1 of 2 entries say "Restated". Latest entry: FY2017.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Sales Region and Monetization Risk for Products Developed at the India Joint Research InstituteA theme 1 companies write about · 1 as a headwind · 0 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2017RestatedAnnual report
「製品の販売地域の市場動向によっては、当社グループの期待する収益が得られない可能性もあり、その場合には当社グループの経営成績に影響を及ぼす可能性があります。」
インド共同研究所の成果について、販売地域の市場動向により期待収益を得られないリスクが継続して記載された。 - FY2016First statedAnnual report
「If the research and development process results in the launch of a crop protection product, the agreement with IIL and the Company distinguishes their sales regions to avoid conflicts of interest. Depending on market conditions in the product’s sales regions, the Group may not generate the expected revenue, which could affect its business performance.」
The disclosure identifies the risk that market conditions in the sales regions for products developed through the joint research facility in India could prevent the Group from earning its expected revenue.